<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T20:28:25Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/7042" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/7042</identifier><datestamp>2024-12-13T09:44:29Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>com_2072_378071</setSpec><setSpec>col_2072_378092</setSpec><setSpec>col_2072_378097</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Angiogenin in the Neurogenic Subventricular Zone After Stroke</dc:title>
   <dc:creator>Gabriel Salazar, Marina</dc:creator>
   <dc:creator>Lei (Santiago), Ting</dc:creator>
   <dc:creator>Grayston Morales, Alba</dc:creator>
   <dc:creator>Costa Riu, Carme</dc:creator>
   <dc:creator>Medina Gutierrez, Esperanza</dc:creator>
   <dc:creator>Montaner Villalonga, Joan</dc:creator>
   <dc:creator>Rosell Novel, Anna</dc:creator>
   <dc:creator>Comabella Lopez, Manuel</dc:creator>
   <dc:contributor>Institut Català de la Salut</dc:contributor>
   <dc:contributor>[Gabriel-Salazar M, Lei T, Grayston A, Medina-Gutiérrez E, Montaner J, Rosell A] Laboratori de Recerca Neurovascular, Servei de Neurologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Costa C, Comabella M] Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain</dc:contributor>
   <dc:contributor>Vall d'Hebron Barcelona Hospital Campus</dc:contributor>
   <dc:subject>Cèl·lules mare neurals</dc:subject>
   <dc:subject>Malalties cerebrovasculars - Tractament</dc:subject>
   <dc:subject>ANATOMY::Cells::Stem Cells::Neural Stem Cells</dc:subject>
   <dc:subject>DISEASES::Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Cerebrovascular Disorders::Stroke</dc:subject>
   <dc:subject>Other subheadings::Other subheadings::/therapy</dc:subject>
   <dc:subject>ANATOMÍA::células::células madre::células madre nerviosas</dc:subject>
   <dc:subject>ENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::trastornos cerebrovasculares::accidente cerebrovascular</dc:subject>
   <dc:subject>Otros calificadores::Otros calificadores::/terapia</dc:subject>
   <dc:description>Angiogenina; Exercici; Neuroreparació</dc:description>
   <dc:description>Angiogenina; Ejercicio; Neuroreparación</dc:description>
   <dc:description>Angiogenin; Exercise; Neurorepair</dc:description>
   <dc:description>Ischemic stroke is a leading cause of death and disability worldwide with effective acute thrombolytic treatments. However, brain repair mechanisms related to spontaneous or rehabilitation-induced recovery are still under investigation, and little is known about the molecules involved. The present study examines the potential role of angiogenin (ANG), a known regulator of cell function and metabolism linked to neurological disorders, focusing in the neurogenic subventricular zone (SVZ). Angiogenin expression was examined in the mouse SVZ and in SVZ-derived neural stem cells (NSCs), which were exposed to exogenous ANG treatment during neurosphere formation as well as in other neuron-like cells (SH-SY5Y). Additionally, male C57Bl/6 mice underwent a distal permanent occlusion of the middle cerebral artery to study endogenous and exercise-induced expression of SVZ-ANG and neuroblast migration. Our results show that SVZ areas are rich in ANG, primarily expressed in DCX+ neuroblasts but not in nestin+NSCs. In vitro, treatment with ANG increased the number of SVZ-derived NSCs forming neurospheres but could not modify SH-SY5Y neurite differentiation. Finally, physical exercise rapidly increased the amount of endogenous ANG in the ipsilateral SVZ niche after ischemia, where DCX-migrating cells increased as part of the post-stroke neurogenesis process. Our findings position for the first time ANG in the SVZ during post-stroke recovery, which could be linked to neurogenesis.</dc:description>
   <dc:description>MG-S was supported by a pre-doctoral fellowship from the Vall d'Hebron Research Institute, AR was supported by the Miguel Servet program and AG holds a pre-doctoral fellowship both from Instituto Carlos III (CPII15/00003 and FI17/00073, respectively), and TL was supported by the China Scholarship Council (CSC-201706170048). This research has been funded by grants PI16/00981, PI19/00186, and RD16/0019/0021 (RETICS-INVICTUS PLUS) from the Instituto de Salud Carlos III co-financed by the European Regional Development Funds, and by the Generalitat de Catalunya (2017SGR 1427).</dc:description>
   <dc:date>2022-02-21T09:44:05Z</dc:date>
   <dc:date>2022-02-21T09:44:05Z</dc:date>
   <dc:date>2021-06-21</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>Gabriel-Salazar M, Lei T, Grayston A, Costa C, Medina-Gutiérrez E, Comabella M, et al. Angiogenin in the Neurogenic Subventricular Zone After Stroke. Front Neurol. 2021 Jun 21;12:941.</dc:identifier>
   <dc:identifier>1664-2295</dc:identifier>
   <dc:identifier>https://hdl.handle.net/11351/7042</dc:identifier>
   <dc:identifier>10.3389/fneur.2021.662235</dc:identifier>
   <dc:identifier>34234733</dc:identifier>
   <dc:identifier>000669466900001</dc:identifier>
   <dc:identifier>http://hdl.handle.net/11351/7042</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Frontiers in Neurology;12</dc:relation>
   <dc:relation>https://doi.org/10.3389/fneur.2021.662235</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/ES/PE2013-2016/CPII15%2F00003</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/ES/PE2013-2016/FI17%2F00073</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F00981</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F00186</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/ES/PE2013-2016/RD16%2F0019%2F0021</dc:relation>
   <dc:rights>Attribution 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Frontiers Media</dc:publisher>
   <dc:source>Scientia</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>